Literature DB >> 31290345

Recurrence of spinal meningiomas: analysis of the risk factors.

Francesco Maiuri1, Marialaura Del Basso De Caro2, Oreste de Divitiis1, Elia Guadagno2, Giuseppe Mariniello1.   

Abstract

Objective: Spinal meningiomas are slow-growing tumors with low recurrence rate after complete resection. The aim of this study is to investigate the risk factors correlated to the recurrence.Material and
Methods: Six patients with spinal WHO grade I meningiomas which recurred after complete resection were reviewed and compared to 50 patients with no recurrence; the data were also compared with those of 50 intracranial meningiomas which recurred and 50 which did not recur after complete resection. The investigated factors included age and sex, tumor location and size, type of arachnoid interface, entity of resection (Simpson I or II), tumor consistency and vascularity, histological type, Ki-67 MIB-1, progesterone receptor (PR) and estrogen receptor (ER) expression. The data were statistically analyzed with the Kaplan-Meier method.
Results: The statistical analysis showed that the presence of arachnoidal invasion (p = 0.023) and higher Ki-67 LI (p < 0.0001) were the only two significant risk factors for recurrence for both spinal and intracranial meningiomas. Large tumor size (p = 0.012), Simpson grade II resection (p = 0.03) and the absence of PR expression (p < 0.0001) were significant risk factors for recurrence of intracranial but not spinal meningiomas. Finally, age and sex, tumor location, consistency and vascularity, histological type, and ER expression were not correlated to recurrence for both localizations.Conclusions: The proliferation index Ki-67 and the arachnoid invasion are the risk factors for recurrence of spinal meningiomas, whereas tumor size, dural resection and PR expression are not significant. The small tumor size and the limited dural invasion may contribute to explain the lower recurrence rate.

Entities:  

Keywords:  Spinal meningioma; intracranial meningioma; progesterone receptor; recurrence

Mesh:

Substances:

Year:  2019        PMID: 31290345     DOI: 10.1080/02688697.2019.1638886

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  4 in total

1.  Surgical results of the resection of spinal meningioma with the inner layer of dura more than 10 years after surgery.

Authors:  Hiroyuki Tominaga; Ichiro Kawamura; Kosei Ijiri; Kazunori Yone; Noboru Taniguchi
Journal:  Sci Rep       Date:  2021-02-18       Impact factor: 4.379

2.  Proliferative Potential, and Inflammatory Tumor Microenvironment in Meningioma Correlate with Neurological Function at Presentation and Anatomical Location-From Convexity to Skull Base and Spine.

Authors:  Johannes Wach; Tim Lampmann; Ági Güresir; Hartmut Vatter; Ulrich Herrlinger; Albert Becker; Silvia Cases-Cunillera; Michael Hölzel; Marieta Toma; Erdem Güresir
Journal:  Cancers (Basel)       Date:  2022-02-18       Impact factor: 6.639

3.  MAC-spinal meningioma score: A proposal for a quick-to-use scoring sheet of the MIB-1 index in sporadic spinal meningiomas.

Authors:  Johannes Wach; Motaz Hamed; Tim Lampmann; Ági Güresir; Frederic Carsten Schmeel; Albert J Becker; Ulrich Herrlinger; Hartmut Vatter; Erdem Güresir
Journal:  Front Oncol       Date:  2022-08-26       Impact factor: 5.738

4.  Progesterone Receptor Expression in Meningiomas: Pathological and Prognostic Implications.

Authors:  Francesco Maiuri; Giuseppe Mariniello; Oreste de Divitiis; Felice Esposito; Elia Guadagno; Giuseppe Teodonno; Marcello Barbato; Marialaura Del Basso De Caro
Journal:  Front Oncol       Date:  2021-07-15       Impact factor: 6.244

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.